Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries This study covers the world outlook for thoracotomy lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics This study covers the world outlook for chemotherapy and other multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments This study covers the world outlook for gastric cancer diagnostics, screenings, and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics This study covers the world outlook for uterine cancer therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics This study covers the world outlook for uterine cancer treatments and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics This study covers the world outlook for ovarian cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics This study covers the world outlook for ovarian cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Drugs
The 2025-2030 World Outlook for Gastric Cancer Drugs This study covers the world outlook for gastric cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Malignant Mesothelioma
The 2025-2030 World Outlook for Malignant Mesothelioma This study covers the world outlook for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Silent Cancer Therapeutics
The 2025-2030 World Outlook for Silent Cancer Therapeutics This study covers the world outlook for silent cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Oncology Information System Software
The 2025-2030 World Outlook for Oncology Information System Software This study covers the world outlook for oncology information system software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Oncology Information Systems
The 2025-2030 World Outlook for Oncology Information Systems This study covers the world outlook for oncology information systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2023-2028 World Outlook for Endocrine Pancreatic Cancer Drugs
The 2023-2028 World Outlook for Endocrine Pancreatic Cancer Drugs This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2023-2028 World Outlook for Gynaecological Cancer Drugs
The 2023-2028 World Outlook for Gynaecological Cancer Drugs This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2023-2028 World Outlook for Cancer Supportive Care Drugs
The 2023-2028 World Outlook for Cancer Supportive Care Drugs This study covers the world outlook for cancer supportive care drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2023-2028 World Outlook for Colorectal Cancer Therapeutics
The 2023-2028 World Outlook for Colorectal Cancer Therapeutics This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2023-2028 World Outlook for Cutaneous Melanoma Therapeutics
The 2023-2028 World Outlook for Cutaneous Melanoma Therapeutics This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2023-2028 World Outlook for Liver Cancer Drugs
The 2023-2028 World Outlook for Liver Cancer Drugs This study covers the world outlook for liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2023-2028 World Outlook for Cancer Liquid Biopsy Products
The 2023-2028 World Outlook for Cancer Liquid Biopsy Products This study covers the world outlook for cancer liquid biopsy products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2023-2028 World Outlook for Prostate Cancer Treatments
The 2023-2028 World Outlook for Prostate Cancer Treatments This study covers the world outlook for prostate cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2023-2028 World Outlook for Ovarian Cancer Drugs
The 2023-2028 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2023-2028 World Outlook for Next Generation Cancer Diagnostics
The 2023-2028 World Outlook for Next Generation Cancer Diagnostics This study covers the world outlook for next generation cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2023-2028 World Outlook for Non-Hematological Cancers
The 2023-2028 World Outlook for Non-Hematological Cancers This study covers the world outlook for non-hematological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2023-2028 World Outlook for Non-Melanoma Skin Cancers
The 2023-2028 World Outlook for Non-Melanoma Skin Cancers This study covers the world outlook for non-melanoma skin cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2023-2028 World Outlook for Pancreatic Cancer Treatments
The 2023-2028 World Outlook for Pancreatic Cancer Treatments This study covers the world outlook for pancreatic cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
Research Assistance
